Cavitation-Enhanced Drug Delivery and Immunotherapy
Cavitation-Enhanced Drug Delivery and Immunotherapy is a rapidly evolving area that has been buoyed in recent years by the development of methods harnessing the activity of ultrasound-stimulated bubbles, known as cavitation. When properly controlled, cavitation can help overcome physical barriers to...
Kaydedildi:
| Diğer Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Elektronik Kitap Bölümü |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Konular: | |
| Online Erişim: | DOAB: download the publication DOAB: description of the publication |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_128825 | ||
| 005 | 20231130 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9435-4 | ||
| 020 | |a 9783036594347 | ||
| 020 | |a 9783036594354 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9435-4 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 072 | 7 | |a TCB |2 bicssc | |
| 100 | 1 | |a Helfield, Brandon |4 edt | |
| 700 | 1 | |a Sirsi, Shashank |4 edt | |
| 700 | 1 | |a Kwan, James |4 edt | |
| 700 | 1 | |a Gray, Michael |4 edt | |
| 700 | 1 | |a Helfield, Brandon |4 oth | |
| 700 | 1 | |a Sirsi, Shashank |4 oth | |
| 700 | 1 | |a Kwan, James |4 oth | |
| 700 | 1 | |a Gray, Michael |4 oth | |
| 245 | 1 | 0 | |a Cavitation-Enhanced Drug Delivery and Immunotherapy |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (260 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Cavitation-Enhanced Drug Delivery and Immunotherapy is a rapidly evolving area that has been buoyed in recent years by the development of methods harnessing the activity of ultrasound-stimulated bubbles, known as cavitation. When properly controlled, cavitation can help overcome physical barriers to drug delivery whilst providing readily measurable information for timely quantitative feedback and treatment guidance. Microbubble-assisted therapies have demonstrated impressive advancements in clinical trials and pre-clinical areas, including applications in neurology, oncology, cardiology and beyond. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 650 | 7 | |a Biotechnology |2 bicssc | |
| 653 | |a passive cavitation detection | ||
| 653 | |a size-isolated microbubbles | ||
| 653 | |a focused ultrasound | ||
| 653 | |a stable cavitation | ||
| 653 | |a inertial cavitation | ||
| 653 | |a perfluoropentane microdroplets | ||
| 653 | |a cavitation | ||
| 653 | |a microfluidic emulsion manufacturing | ||
| 653 | |a polydispersity | ||
| 653 | |a ultrasound contrast agent | ||
| 653 | |a ultrasound duty cycle | ||
| 653 | |a intravascular ultrasound | ||
| 653 | |a ultrasound | ||
| 653 | |a targeted drug delivery | ||
| 653 | |a microbubble | ||
| 653 | |a sonoporation | ||
| 653 | |a nanoparticle | ||
| 653 | |a gene therapy | ||
| 653 | |a miRNA delivery | ||
| 653 | |a microRNA-126 | ||
| 653 | |a microbubbles | ||
| 653 | |a endothelial cells | ||
| 653 | |a HUVEC | ||
| 653 | |a therapeutic angiogenesis | ||
| 653 | |a round window membrane | ||
| 653 | |a metabolomics | ||
| 653 | |a perilymph | ||
| 653 | |a inner ear | ||
| 653 | |a SonoCloud | ||
| 653 | |a GL261 mouse model | ||
| 653 | |a ultrasound-mediated drug delivery | ||
| 653 | |a glioblastoma | ||
| 653 | |a immune checkpoint inhibitors | ||
| 653 | |a radiotherapy | ||
| 653 | |a tumor hypoxia | ||
| 653 | |a contrast-enhanced ultrasound | ||
| 653 | |a oxygen-loaded microbubbles | ||
| 653 | |a drug delivery | ||
| 653 | |a head and neck cancer | ||
| 653 | |a lonidamine | ||
| 653 | |a metformin | ||
| 653 | |a cavitation nuclei | ||
| 653 | |a Biofilm | ||
| 653 | |a microbubble targeting | ||
| 653 | |a cationic microbubble | ||
| 653 | |a ultrasound drug delivery | ||
| 653 | |a pancreatic cancer | ||
| 653 | |a paclitaxel | ||
| 653 | |a gemcitabine | ||
| 653 | |a cetuximab | ||
| 653 | |a SonoTran Particles | ||
| 653 | |a passive acoustic mapping | ||
| 653 | |a large animal cancer model | ||
| 653 | |a targeted microbubbles | ||
| 653 | |a ultrasound imaging probes | ||
| 653 | |a ultrasound-targeted delivery | ||
| 653 | |a therapy | ||
| 653 | |a immunotherapy | ||
| 653 | |a ultrasound targeting | ||
| 653 | |a acoustic droplet vaporization | ||
| 653 | |a cancer | ||
| 653 | |a checkpoint inhibitor | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8293 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128825 |7 0 |z DOAB: description of the publication |